Medicare’s decision to expand access to weight loss drugs marks a pivotal shift in healthcare policy as demand for GLP-1 medications rises rapidly across the U.S. A Gallup poll reveals that 11% of American adults now use these drugs, up from just 3% two years prior. This growing adoption is being supported by new discount programs that allow certain Medicare beneficiaries to obtain treatment at reduced costs. William Brangham and Juliette Cubanski examine the broader implications of this change, including how increased availability may strain healthcare resources and reshape long-term treatment models.
NovaTube News delivers live video news content sourced directly from YouTube. The platform aggregates publicly available videos using the YouTube Data API and streams them through official YouTube links. No account registration is required to view content. Minimal technical data such as device and browser information is collected anonymously to enhance service performance. The site uses only essential cookies for functionality and does not deploy tracking technologies for advertising. All video content remains subject to YouTube’s privacy policies when accessed through their platform.